Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Pharma Industry Analysis

UpdatedApr 10, 2026
DataAggregated Company Financials
Companies23
  • 7D2.7%
  • 3M-23.0%
  • 1Y-10.5%
  • YTD-18.4%

The Pharma industry is up 2.7% in the last week, with Camurus up 4.1%. In contrast, the industry has lost 10% in the last 12 months. Looking forward, earnings are forecast to grow by 35% annually.

Industry Valuation and Performance

Has the Swedish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 10 Apr 2026SEK 42.6bSEK 5.3b-SEK 1,376,536,671.0058.2x-31x8.1x
Sun, 08 Mar 2026SEK 41.3bSEK 5.3b-SEK 1,377,968,671.0054.6x-30x7.8x
Tue, 03 Feb 2026SEK 51.6bSEK 5.3b-SEK 1,000,645,157.0056x-51.6x9.7x
Thu, 01 Jan 2026SEK 49.9bSEK 5.3b-SEK 531,735,157.0072.3x-93.8x9.4x
Sat, 29 Nov 2025SEK 50.1bSEK 5.3b-SEK 524,494,177.0071.4x-95.5x9.5x
Mon, 27 Oct 2025SEK 51.0bSEK 5.1b-SEK 433,356,865.0076.5x-117.8x9.9x
Wed, 24 Sep 2025SEK 54.7bSEK 5.1b-SEK 405,183,865.0069.9x-135.1x10.8x
Fri, 22 Aug 2025SEK 55.9bSEK 5.1b-SEK 327,869,676.0076.3x-170.6x11x
Sun, 20 Jul 2025SEK 57.5bSEK 5.0b-SEK 347,188,364.0069.2x-165.7x11.4x
Tue, 17 Jun 2025SEK 50.8bSEK 4.8b-SEK 574,360,325.5767.8x-88.4x10.5x
Thu, 15 May 2025SEK 51.2bSEK 4.7b-SEK 721,249,923.8277.7x-71x11x
Sat, 12 Apr 2025SEK 45.9bSEK 4.7b-SEK 807,022,812.2265.7x-56.9x9.7x
Mon, 10 Mar 2025SEK 50.7bSEK 4.7b-SEK 812,279,592.8774.1x-62.5x10.8x
Wed, 05 Feb 2025SEK 51.6bSEK 4.4b-SEK 809,776,700.87131.4x-63.8x11.7x
Fri, 03 Jan 2025SEK 51.3bSEK 4.4b-SEK 615,624,740.84123.3x-83.4x11.5x
Sun, 01 Dec 2024SEK 51.1bSEK 4.4b-SEK 620,570,905.25126.9x-82.3x11.5x
Tue, 29 Oct 2024SEK 52.3bSEK 4.3b-SEK 684,764,847.99138.5x-76.3x12.1x
Thu, 26 Sep 2024SEK 64.1bSEK 5.9b-SEK 1,169,974,026.22166.6x-54.8x10.9x
Sat, 24 Aug 2024SEK 68.9bSEK 5.9b-SEK 937,246,156.0688.7x-73.5x11.7x
Mon, 22 Jul 2024SEK 67.0bSEK 5.5b-SEK 997,468,990.47111.3x-67.2x12.1x
Wed, 19 Jun 2024SEK 62.8bSEK 6.4b-SEK 862,334,724.2872x-72.8x9.9x
Fri, 17 May 2024SEK 53.5bSEK 6.4b-SEK 803,390,178.5271.6x-66.6x8.4x
Sun, 14 Apr 2024SEK 51.3bSEK 6.2b-SEK 1,040,626,304.1977.9x-49.3x8.2x
Tue, 12 Mar 2024SEK 50.3bSEK 6.2b-SEK 1,038,038,025.2677.8x-48.4x8.1x
Thu, 08 Feb 2024SEK 53.7bSEK 6.0b-SEK 933,078,927.2969.2x-57.5x9x
Sat, 06 Jan 2024SEK 69.1bSEK 9.4b-SEK 1,184,310,332.0064.2x-58.3x7.3x
Mon, 04 Dec 2023SEK 62.4bSEK 9.5b-SEK 1,209,395,296.0057.1x-51.6x6.6x
Wed, 01 Nov 2023SEK 52.8bSEK 9.3b-SEK 1,115,133,430.0082.2x-47.3x5.7x
Fri, 29 Sep 2023SEK 51.3bSEK 9.2b-SEK 1,177,245,024.00127.2x-43.6x5.6x
Sun, 27 Aug 2023SEK 50.3bSEK 9.2b-SEK 1,127,087,548.0079.3x-44.7x5.5x
Tue, 25 Jul 2023SEK 51.0bSEK 8.8b-SEK 1,370,056,630.0073.7x-37.2x5.8x
Thu, 22 Jun 2023SEK 48.3bSEK 8.4b-SEK 1,693,091,160.0073.9x-28.5x5.8x
Sat, 20 May 2023SEK 48.2bSEK 8.4b-SEK 1,756,072,533.0082.6x-27.4x5.8x
Mon, 17 Apr 2023SEK 46.1bSEK 8.0b-SEK 1,795,014,667.0090.4x-25.7x5.8x
Price to Earnings Ratio

-25.7x


Total Market Cap: SEK 46.1bTotal Earnings: -SEK 1,795,014,667.00Total Revenue: SEK 8.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Pharma Industry Price to Earnings3Y Average -73.7x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 9.1x is higher than the industry's current PS ratio of 8.1x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 13% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market3.33%
Healthcare1.00%
Pharma2.68%
Pharma2.68%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CAMX CamurusSEK 503.504.1%
+SEK 1.2b		-7.2%PE40.9x
SECARE SwedencareSEK 26.204.0%
+SEK 159.8m		-26.2%PE75.5x
KLAR Klaria Pharma Holding AB (publ.)SEK 1.1217.4%
+SEK 40.8m		-8.0%PS30.6x
IBT B Infant Bacterial TherapeuticsSEK 50.001.2%
+SEK 8.1m		-8.8%PB6.4x
IRLAB A IRLAB TherapeuticsSEK 1.494.5%
+SEK 5.4m		-79.0%PS2.2x

Latest News

KDV B
SEK 0.25
KDventures
7D
-2.7%
1Y
-70.6%
KLAR
SEK 1.12
Klaria Pharma Holding AB (publ.)
7D
17.4%
1Y
-8.0%
MOB
SEK 9.80
Moberg Pharma
7D
-6.7%
1Y
36.0%

MOB: Dual Terbinafine Sourcing Will Support Future Re Rating Potential

Analysts have reaffirmed their price target for Moberg Pharma at SEK 13.0 per share, citing unchanged views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Regulators have approved an additional supplier of terbinafine for MOB-015, Moberg Pharma's drug for nail fungus, after a process that started in April 2024 (Key Developments).
ORX
SEK 20.75
Orexo
7D
-6.7%
1Y
46.5%
CAMX
SEK 503.50
Camurus
7D
4.1%
1Y
-7.2%

CAMX: FDA Review Of Resubmitted NDA Will Drive Future Upside

Analysts have trimmed their 12 month price target for Camurus from SEK 660 to SEK 610, citing updated assumptions that include revised revenue growth, profit margin and future P/E expectations. What's in the News Camurus issued earnings guidance for 2026, with expected revenues of SEK 2.6b to SEK 2.9b and an operating result of SEK 0.9b to SEK 1.2b, framed against internal 2025 expectations (Key Developments).
IBT B
SEK 50.00
Infant Bacterial Therapeutics
7D
1.2%
1Y
-8.8%
ACUC
SEK 0.76
AcuCort
7D
2.0%
1Y
-9.9%
ANNX
SEK 13.75
Annexin Pharmaceuticals
7D
2.6%
1Y
-52.6%
SECARE
SEK 26.20
Swedencare
7D
4.0%
1Y
-26.2%
PILA
SEK 1.68
Pila Pharma
7D
-19.4%
1Y
-47.5%
FLERIE
SEK 28.80
Flerie
7D
-3.0%
1Y
-29.8%
IRLAB A
SEK 1.49
IRLAB Therapeutics
7D
4.5%
1Y
-79.0%
CESSA
DKK 16.60
Cessatech
7D
-7.5%
1Y
96.2%
ALZCUR
SEK 1.48
AlzeCure Pharma
7D
-13.2%
1Y
-40.8%
DICOT
SEK 0.40
Dicot Pharma
7D
-5.7%
1Y
45.5%

Is Dicot Pharma (STO:DICOT) In A Good Position To Invest In Growth?

Feb 03
Is Dicot Pharma (STO:DICOT) In A Good Position To Invest In Growth?
NEWBRY
SEK 1.17
Newbury Pharmaceuticals
7D
9.3%
1Y
-65.2%